High density lipoprotein receptors, binding proteins, and ligands

Journal of Lipid Research

Volumn 40, Issue 2, 1999, Pages 187-201

  Fidge, Noel H ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Activated leukocyte cell adhesion molecule; Apolipoprotein E; Biochemical signalling; Cholesterol; HB2; HBP; Ligands; SR BI

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN C; BINDING PROTEIN; CD36 ANTIGEN; CELL ADHESION MOLECULE; CHOLESTEROL; CHOLESTEROL ESTER; CHORIONIC GONADOTROPIN; CYSTEINE; ESTROGEN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN RECEPTOR; HYPOPHYSIS HORMONE; LIGAND; LIPID TRANSFER PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MEMBRANE PROTEIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLINOSITOL; PHOSPHOLIPID; PROTEIN KINASE C; STEROID HORMONE; UNCLASSIFIED DRUG; VIGILIN; CARRIER PROTEIN; HIGH DENSITY LIPOPROTEIN BINDING PROTEIN; HIGH DENSITY LIPOPROTEIN RECEPTORS; IMMUNOGLOBULIN RECEPTOR; LIPOPROTEIN RECEPTOR; RNA BINDING PROTEIN; SCARB1 PROTEIN, HUMAN; SCARB1 PROTEIN, MOUSE; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR B;

AMINO TERMINAL SEQUENCE; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY; STEROIDOGENESIS; ANIMAL; BIOLOGICAL MODEL; ENZYME SPECIFICITY; GENETICS; METABOLISM; MOLECULAR CLONING; PHYSIOLOGY; PROTEIN BINDING; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD36; APOLIPOPROTEIN A-I; BINDING SITES; CARRIER PROTEINS; CELL ADHESION MOLECULES; CLONING, MOLECULAR; HUMANS; LIGANDS; LIPOPROTEINS, HDL; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; PROTEIN BINDING; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOPROTEIN; RECEPTORS, SCAVENGER; RNA-BINDING PROTEINS; SCAVENGER RECEPTORS, CLASS B; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY;

EID: 0032930315     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Suzuki, N., N. Fidge, P. Nestel, and J. Yin. 1983. Interaction of serum lipoproteins with the intestine: evidence for specific high density lipoprotein-binding sites on isolated rat intestinal mucosal cells. J. Lipid Res. 24: 253-264.
2. Biesbroeck, R., J. F. Oram, J. J. Albers and E. L. Bierman. 1983. Specific high affinity binding of high density lipoprotein to cultured human skin fibroblasts and arterial smooth muscle cells. J. Clin. Invest. 71: 525-539.
3. Bachorik, P. S., F. A. Franklin, D. G. Virgil, and P. O. Kwiterovich. 1982. High affinity uptake and degradation of apolipoprotein E-free high density lipoprotein and low density lipoprotein in cultured porcine hepatocytes. Biochemistry. 21: 5675-5684.
4. Barbaras, R., Grimaldi, P. R. Negrel, and G. Ailhaud. 1986. Characterization of high-density lipoprotein binding and cholesterol efflux in cultured mouse adipose cells. Biochim. Biophys. Acta. 888: 143-156.
5. Chen, Y. I., F. B. Kraemer, and G. M. Reaven. 1980. Identification of specific high density lipoprotein-binding sites in rat testis and regulation of binding by human chorionic gonadotropin. J. Biol. Chem. 255: 9162-9167.
6. Morrison, J. R., G. A. McPherson, and N. H. Fidge. 1992. Evidence for two sites on rat liver plasma membranes which interact with high density lipoprotein. J. Biol Chem. 267: 13205-13209.
7. Barbaras, R., X. Collet, H. Chap, and B. Perret. 1994. Specific binding of free apolipoprotein A-I to a high-affinity binding site on HepG2 cells: characterization of two high-density lipoprotein sites. Biochemistry. 33: 2335-2340.
8. Fidge, N., A. Kagami, and M. O'Connor. 1985. Identification of a high density lipoprotein binding protein from adrenocortical membranes. Biochem. Biophys. Res. Commun. 129: 759-765.
9. Fidge, N. 1986. Partial purification of a high density lipoprotein binding protein from rat liver and kidney membranes. FEBS Lett. 199: 265-268.
10. Graham, D. L., and J. F. Oram. 1987. Identification and characterization of a high density lipoprotein-binding protein in cell membranes by ligand blotting. J. Biol. Chem. 262: 7439-7442.
11. Barbaras, R., P. Puchois, J. C. Fruchart, A. Pradines-Figueres, and G. Ailhaud. 1990. Purification of an apolipoprotein A binding protein from mouse adipose cells. Biochem. J. 269: 767-773.
12. Tozuka, M., and N. H. Fidge. 1989. Purification and characterization of two high density lipoprotein binding proteins from rat and human liver. Biochem. J. 261: 239-244.
13. Bond, H. M., G. Morrone, S. Venuta, and K. E. Howell. 1991. Characterization and purification of proteins which bind high density lipoprotein. Biochem. J. 279: 633-641.
14. McKnight, G. L., J. Reasoner, T. Gilbert, K. O. Sundquist, B. Hokland, P. A. McKernan, J. Champagne, C. J. Johnson, M. C. Bailey, R. Holly, P. J. O'Hara, and J. F. Oram. 1992. Cloning and expression of a cellular high density lipoprotein-binding protein that is up-regulated by cholesterol loading of cells. J. Biol. Chem. 267: 12131-12141.
15. Chiu, D. S., J. F. Oram, R. C. LeBoeuf, C. E. Alpers, and K. D. O'Brien. 1997. High-density lipoprotein binding protein (HBP) vigilin is expressed in human atherosclerotic lesions and colocalizes with apolipoprotein E. Arterioscler. Thromb. Vasc. Biol. 17: 2350-2358.
16. Dodson, R. E., and D. J. Shapiro. 1997. Vigilin, a ubiquitous protein with 14 K homology domains, is the estrogen-inducible vitellogenin mRNA 3′-untranslated region-binding protein. J. Biol. Chem. 272: 12249-12252.
17. Oram, J. F., E. A. Brinton, and E. L. Bierman. 1983. Regulation of HDL receptor activity in cultured human skin fibroblasts and human arterial smooth muscle cells. J. Clin. Invest. 72: 1611-1621.
18. Oram, J. F., A. J. Mendez, J. P. Slotte, and T. F. Johnson. 1991. High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts. Arterioscler. Thromb. 11: 403-414.
19. Mendez, A. J., J. F. Oram, and E. L. Bierman. 1991. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J. Biol. Chem. 266: 10104-10111.
20. Brissette, L., and S. P. Noel. 1986. The effects of human low and high density lipoproteins on the binding of rat intermediate density lipoproteins to rat liver membranes. J. Biol. Chem. 261: 6847-6852.
21. Acton, S., A. Rigotti, K. Landschulz, S. Xu, H. H. Hobbs, and M. Krieger. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271: 518-520.
22. Puente Navazo, M. D., L. Daviet, E. Ninio, and J. L. McGregor. 1996. Identification on human CD36 of a domain (155-183) implicated in binding oxidized low-density lipoproteins (Ox-LDL). Arterioscler, Thromb. Vasc. Biol. 16: 1033-1039.
23. Endemann, G., L. W. Stanton, K. S. Madden, C. M. Bryant, R. T. White, and A. A. Protter. 1993. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268: 11811-11816.
24. Pittman, R. C., T. P. Knecht, M. S. Rosenbaum, and C. A. Taylor, Jr. 1987. A nonendocytotic mechanism for the selective uptake of high density lipoprotein-associated cholesterol esters. J. Biol. Chem. 262: 2443-2450.
25. Brissette, L., M. C. Charest, and L. Falstrault. 1996. Selective uptake of cholesteryl esters of low-density lipoproteins is mediated by the lipoprotein-binding site in HepG2 cells and is followed by the hydrolysis of cholesteryl esters. Biochem. J. 318: 841-847.
26. Tao, N., S. J. Wagner, and D. M. Lublin. 1996. CD36 is palmitoylated on both N- and C-terminal cytoplasmic tails. J. Biol. Chem. 271: 22315-22320.
27. Babitt, J., B. Trigatti, A. Rigotti, E. J. Smart, R. G. W. Anderson, S. Xu, and M. Krieger. 1997. Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J. Biol. Chem. 272: 13242-13249.
28. Landschulz, K. T., R. K. Pathak, A. Rigotti, M. Krieger, and H. H. Hobbs. 1996. Regulation of scavenger receptor, class B. type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J. Clin. Invest. 98: 984-995.
29. Mizutani, T., Y. Sonoda, T. Minegishi, K. Wakabayashi, and K. Miyamoto. 1997. Cloning, characterization, and cellular distribution of rat scavenger receptor class B type I (SRBI) in the ovary. Biochem. Biophys. Res. Commun. 234: 499-505.
30. Rigotti, A., E. R. Edelman, P. Seifert, S. N. Iqbal, R. B. DeMattos, R. E. Temel, M. Krieger, and D. L. Williams. 1996. Regulation by adrenocorticotropic hormone of the in vivo expression of scavenger receptor class B type I (SR-BI), a high density lipoprotein receptor, in steroidogenic cells of the marine adrenal gland. J. Biol. Chem. 271: 33545-33549.
31. Carr, B. R., C. R. Parker, Jr., L. Milewich, J. C. Porter, P. C. MacDonald, and E. R. Simpson. 1980. The role of low density, high density, and very low density lipoproteins in steriodogenesis by the human fetal adrenal gland. Endocrinology. 106: 1854-1861.
32. Illingworth, D. R., T. A. Kenny, and E. S. Orwoll. 1982. Adrenal function in heterozygous and homozygous hypobetalipoproteinemia. J. Clin. Endocrinol. Metab. 54: 27-33.
33. Illingworth, D. R., D. K. Corbin, E. D. Kemp, and E. J. Keenan. 1982. Hormone changes during the menstrual cycle in abetalipoproteinemia: reduced luteal phase progesterone in a patient with homozygous hypobetalipoproteinemia. Proc. Natl. Acad. Sci. USA. 79: 6685-6689.
34. Ji, Y., B. Jian, N. Wang, Y. Sun, M. de la Llera Moya, M. C. Phillips, G. H. Rothblat, J. B. Swaney, and A. R. Tall. 1997. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272: 20982-20985.
35. Steinberg, D. 1996. A docking receptor for HDL cholesterol esters. Science. 271: 460-461.
36. Gu, X., B. Trigatti, S. Xu, S. Acton, J. Babitt, and M. Krieger. 1998. The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. J. Biol. Chem. 273: 26338-26348.
37. Hauser, H., J. H. Dyer, A. Nandy, M. A. Vega, M. Werder, E. Bieliauskaite, F. E. Weber, S. Compassi, A. Gemperli, D. Boffelli, E. Wehrli, G. Schulthess, and M. C. Phillips. 1998. Identification of a receptor mediating absorption of dietary cholesterol in the intestine. Biochemistry. 37: 17843-17850.
38. Fluiter, K., D. R. van der Westhuijzen, and T. J. C van Berkel. 1998. In vivo regulation of scavenger receptor BI and the selective uptake of high density lipoprotein cholesteryl esters in rat liver parenchymal and Kupffer cells. J. Biol. Chem. 273: 8434-8438.
39. Wang, N., W. Weng, J. L. Breslow, and A. R. Tall. 1996. Scavenger receptor BI (SR-BI) is up-regulated in adrenal gland in apolipoprotein A-I and hepatic lipase knock-out mice as a response to depletion of cholesterol stores. J. Biol. Chem. 271: 21001-21004.
40. Kozarsky, K. F., M. H. Donahee, A. Rigotti, S. N. Iqbal, E. R. Edelman, and M. Krieger. 1997. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature. 387: 414-417.
41. Murao, K., V. Terpstra, S. R. Green, N. Kondratenko, D. Steinberg, and O. Quehenberger. 1997. Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J. Biol. Chem. 272: 17551-17557.
42. Hatzopoulos, A. K., A. Rigotti, R. D. Rosenberg, and M. Krieger. 1998. Temporal and spatial pattern of expression of the HDL receptor SR-BI during murine embryogenesis. J. Lipid Res. 39: 495-508.
43. Webb, N. R., P. M. Connell, A. Graf, J. Smart, J. S. de Villiers, C. de Beer, and R. van der Westhuyzen. 1998. SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J. Biol. Chem. 273: 15241-15248.
44. Hidaka, H., and N. H. Fidge. 1992. Affinity purification of the hepatic high density lipoprotein receptor identifies two acidic glycoproteins and enables further characterization of their binding properties. Biochem. J. 284: 161-167.
45. Mathai, D., N. H. Fidge, M. Tozuka, and A. Mitchell. 1990. Simvastatin and cholestyramine treatment reduces the level of expression of high density lipoprotein binding proteins in rat liver. Arteriosclerosis. 10: 1045-1050.
46. Matsumoto, A., A. Mitchell, H. Kurata, L. Pyle, K. Kondo, H. Itakura, and N. H. Fidge. 1997. Cloning and characterization of HB2, a candidate high density lipoprotein receptor: sequence homology with membranes of the immunoglobulin superfamily of membrane proteins. J. Biol. Chem. 272: 16778-16782.
47. Bowen, M. A., D. D. Patel, X. Li, B. Modrell, A. R. Malacko, W. C. Wang, H. Marquardt, M. Neubauer, J. M. Pesando, U. Francke, B. F. Haynes, and A. Aruffo. 1995. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J. Exp. Med. 181: 2213-2220.
48. Pourquie, O., C. Corbel, J. P. Le Caer, J. Rossier, and N. M. Le Douarin. 1992. BEN, a surface glycoprotein of the immunoglobulin superfamily, is expressed in a variety of developing systems. Proc. Natl. Acad. Sci. USA. 89: 5261-5265.
49. 2 (HDL binding protein) in rabbit. Proceedings of the XIII International Symposium on Drugs Affecting Lipid Metabolism. 26.
50. Lutton, C., and N. H. Fidge. 1994. Distribution of high density lipoprotein binding proteins among various tissues in the rat. C. R. Acad. Sci. 317: 731-735.
51. Bowen, M., A. J. Bajorath, A. W. Siadak, B. Modrell, A. R. Malacko, H. Marquardt, S. G. Nadler, and A. Aruffo. 1996. The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stoichiometry. J. Biol Chem. 271: 17390-17396.
52. Cockerill, G. W., K. Rye, R. R. Gamble, M. A. Vadas, and P. J. Barter. 1995. High-density lipoproteins inhibit cytokine-induccd expression of endothelial cell adhesion molecules. Arterioscler. Thromb. Vasc. Biol. 15: 1987-1994.
53. Brinton, E. A., J. F. Oram, C. H. Chen, J. J. Albers, and E. L. Bierman. 1986. Binding of high density lipoprotein to cultured fibroblasts after chemical alteration of apoprotein amino acid residues. J. Biol. Chem. 261: 495-503.
54. Xu, S., M. Laccotripe, X. Huang, A. Rigotti, V. I. Zannis, and M. Krieger. 1997. Apolipoproteins of HDL can directly mediate binding to the scavenger receptor SR-BI, an HDL receptor that mediates selective lipid uptake. J. Lipid Res. 38: 1289-1298.
55. Fidge, N. H., and P. J. Nestel. 1985. Identification of apolipoproteins involved in the interaction of human high density lipoprotein 3 with receptors on cultured cells. J. Biol. Chem. 260: 3570-3575.
56. Rifici, V. A., and H. A. Eder. 1984. A hepatocyte receptor for high-density lipoproteins specific for apolipoprotein A-I. J. Biol. Chem. 259: 13814-13818.
57. Schmitz, G., R. Niemann, B. Brennhausen, R. M. Krauss, and G. Assmann. 1985. Regulation of high density lipoprotein receptors in cultured macrophages: role of acyl CoA:cholesterol acyltransferase. EMBO J. 4: 2773-2779.
58. Fong, B. S., A. M. Salter, J. Jimenez, and A. Angel. 1987. The role of apolipoprotein A-I and apolipoprotein A-II in high density lipoprotein binding to human adipocyte plasma membranes. Biochim. Biophys. Acta. 920: 105-113.
59. Hwang, J., and K. M. J. Menon. 1985. Characterization of low density and high density lipoprotein receptors in the rat corpus luteum and regulation by gonadotropin. J. Biol. Chem. 260: 5660-5668.
60. Vadiveloo, P. K., and N. F. Fidge. 1992. The role of apoprotein A-I and A-II in binding of high density lipoproteins to membranes derived from bovine aortic endothelial cells. Biochem. J. 284: 145-151.
61. Puchois, P., A. Kandoussi, P. Fievet, J. L. Fourrier, M. Bertrand, E. Koren, and J. C. Fruchart. 1987. Apolipoprotein A-I-containing lipoproteins in coronary artery disease. Atherosclerosis. 68: 35-40.
62. Johnson, W. J., E. P. C. Kilsdonk, A. van Tol, M. C. Phillips, and G. H. Rothblat. 1991. Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: Lp-AI and Lp-AI, AII. J. Lipid Res. 32: 1993-2000.
63. von Hodenburg, E., S. Heinen, K. E. Howell, C. Luley, W. Kubler, and H. M. Bond. 1991. Cholesterol efflux from macrophages mediated by high density lipoprotein fractions which differ principally in apolipoprotein A-I and apolipoprotein A-II ratios. Biochim. Biophys. Acta. 1086: 173-184.
64. Sviridov, D., and N. H. Fidge. 1995. Efflux of intracellular vs. plasma membrane cholesterol in HepG2 cells: different availability and regulation by apolipoprotein A-I. J. Lipid Res. 36: 1887-1896.
65. Rubin, E. M., R. M. Krauss, E. A. Spangler, J. G. Verstuyft, and S. M. Clift. 1991. Inhibition of early atherosclerosis in transgenic mice by human apolipoprotein A-I. Nature. 353: 265-267.
66. Warden, C. H., C. C. Hedrick, J. H. Qiao, L. W. Castellani, and A. J. Lusis. 1993. Atherosclerosis in transgenic mice overexpressing apoA-II. Science. 261: 469-472.
67. Schultz, J. R., J. G. Verstuyft, E. L. Gong, A. V. Nichols, and E. M. Rubin. 1993. Protein composition determines the antiatherogenic properties of HDL in transgenic mice. Nature. 365: 762-764.
68. Segrest, J. P., M. K. Jones, H. DeLoof, C. G. Brouillette, Y. V. Venkatachalapathi, and G. M. Anantharamaiah. 1992. The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J. Lipid Res. 33: 141-166.
69. Mendez, A. J., G. M. Anantharamaiah, J. P. Segrest, and J. F. Oram. 1994. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol J. Clin. Invest. 94: 1698-1705.
70. Yancey, P. G., J. K. Bielicki, W. J. Johnson, S. Lund-Katz, M. N. Palgunachari, G. M. Anantharamaiah, J. P. Segrest, M. C. Phillips, and G. H. Rothblat. 1995. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry. 34: 7955-7965.
71. Leblond, L., and Y. L. Marcel. 1991. The amphipathic alpha-helical repeats of apolipoprotein A-I are responsible for binding of high density lipoproteins to HepG2 cells. J. Biol. Chem. 266: 6058-6067.
72. Handley, D. A., C. M. Arbeenym, L. D. Witte, and S. Chien. 1981. Colloidal gold-low density lipoprotein conjugates as membrane receptor probes. Proc. Natl. Acad. Sci. USA. 78: 368-371.
73. 3H]cholesteryl linoleate-labeled human low density lipoprotein by cultured rat granulosa cells: cellular mechanisms involved in lipoprotein metabolism and their importance to steroidogenesis. J. Cell Biol. 100: 1235-1247.
74. 2). Biochemistry. 35: 13064-13071.
75. Morrison, J., N. H. Fidge, and M. Tozuka. 1991. Determination of the structural domain of apoA-I recognized by high density lipoprotein receptors. J. Biol. Chem. 266: 18780-18785.
76. Dalton, M. B., and J. B. Swaney. 1993. Structural and functional domains of apolipoprotein A-I within high density lipoproteins. J. Biol Chem. 268: 19274-19283.
77. Allan, C., N. H. Fidge, J. R. Morrison, and J. Kanellos. 1993. Monoclonal antibodies to human apolipoprotein A-I: structural probes for the cellular binding domain of apoA-I. Biochem. J. 290: 449-455.
78. Phillips, M. C., L. R. McLean, G. W. Stoudt, and G. H. Rothblat. 1980. Mechanism of cholesterol efflux from cells. Atherosclerosis. 36: 409-422.
79. Sviridov, D., L. Pyle, and N. H. Fidge. 1996. Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I-containing particles. Biochemistry. 35: 189-196.
80. Fielding, P. E., M. Kawano, A. L. Catapano, A. Zoppo, S. Marcovina, and G. J. Fielding. 1994. Unique epitope of apolipoprotein A-I expressed in prebeta-1 high density lipoprotein and its role in the catalyzed efflux of cellular cholesterol. Biochemistry. 33: 6981-6985.
81. Luchoomun, J., N. Theret, V. Clavey, P. Duchateau, M. Rosseneu, R. Brasseur, P. Denefle, J. C. Fruchart, and G. R. Castro. 1994. Structural domain of apolipoprotein A-I involved in its interaction with cells. Biochem. Biophys. Acta. 1212: 319-326.
82. Banka, C. L., A. S. Black, and L. K. Curtiss. 1994. Localization of an apolipoprotein A-I epitope critical for lipoprotein-mediated cholesterol efflux from monocytic cells. J. Biol. Chem. 269: 10288-10297.
83. Davidson, W. S., S. Lund-Katz, W. J. Johnson, G. M. Anantharamaiah, M. N. Palgunachari, J. P. Segrest, G. H. Rothblat, and M. C. Phillips. 1994. The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein. J. Biol. Chem. 269: 22975-22982.
84. Forte, T. M., R. Goth-Goldstein, R. W. Nordhausen, and M. R. McCall. 1993. Apolipoprotein A-I cell membrane interaction: extracellular assembly of heterogeneous nascent HDL particles. J. Lipid Res. 34: 317-324.
85. Sviridov, D., L. Pyle, and N. H. Fidge. 1996. Efflux of cellular cholesterol and phospholipid to apolipoprotein A-I mutants. J. Biol. Chem. 271: 33277-33283.
86. Neary, R. H., and E. Gowland. 1987. Stability of free apolipoprotein A-I concentration in serum, and its measurement in normal and hyperlipidemic subjects. Clin. Chem. 33: 1163-1169.
87. Liang, H-Q., K-A. Rye, and P. J. Barter. 1994. Dissociation of lipid-free apolipoprotein A-I from high density lipoproteins. J. Lipid Res. 35: 1187-1199.
88. Sparks, D. L., W. S. Davidson, S. Lund-Katz, and M. C. Phillips. 1993. Effect of cholesterol on the charge and structure of apolipoprotein A-I in recombinant high density lipoprotein particles. J. Biol. Chem. 268: 23250-23257.
89. Hara, H., and S. Yokoyama. 1991. Interaction of free apolipoproteins with macrophages: formation of high density lipoproteinlike lipoproteins and reduction of cellular cholesterol. J. Biol. Chem. 266: 3080-3086.
90. Komaba, A., Q. Li, H. Hara, and S. Yokoyama. 1992. Resistance of smooth muscle cells to assembly of high density lipoproteins with extracellular free apolipoproteins and to reduction of intracellularly accumulated cholesterol. J. Biol. Chem. 267: 17560-17566.
91. Holian, O., R. Kumar, and B. Attar. 1991. Apoprotein A-I is a co-factor independent substrate of protein kinase C. Biochem. Biophys. Res. Commun. 179: 599-604.
92. Biran, S., A. T. Horowitz, Z. Fuks, and I. Vlodavsky. 1983. High density lipoprotein and extracellular matrix promotes growth and plating efficiency of normal human mammary epithelial cells in serum-free medium. Int. J. Cancer. 31: 557-566.
93. Favre, G., E. Blancy, J. F. Tournier, and G. Soula. 1989. Proliferative effect of high density lipoprotien (HDL) and HDL fractions (HDL 1.2, HDL3) on virus transformed lymphoblastoid cells. Biochim. Biophys. Acta. 1013: 118-124.
94. Jozan, S., J. C. Faye, J. F. Tournier, J. P. Tauber, J. F. David, and F. Bayard. 1985. Interaction of estradiol and high density lipoproteins on proliferation of the human breast cancer cell line MCF-7 adapted to grow in serum-free conditions. Biochem. Biophys. Res. Commun. 133: 105-112.
95. Garver, W. S., M. A. Deeg, R. F. Bowen, M. M. Culala, E. L. Bierman, and J. F. Oram. 1997. Phosphoproteins, regulated by the interaction of high-density lipoprotein with human skin fibroblasts. Arterioscler. Thromb. Vasc. Biol. 17: 2698-2706.
96. Wu, Y. Q., and S. Handwerger. 1992. High density lipoproteins stimulate molecular weight 80 K protein phosphorylation in human trophoblast cells: evidence for a protein kinase-C-dependent pathway in human placental lactogen release. Endocrinology. 131: 2935-2940.
97. Li, Q., M. Tsujita, and S. Yokoyama. 1997. Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages. Biochemistry. 36: 12045-12052.
98. 3 stimulates multiple signaling pathways in human skin fibroblasts. Arterioscler. Thromb. Vasc. Biol. 15: 1975-1986.
99. Xia P., J. R. Gamble, K. A. Rye, J. Wang, C. S. T. Hii, P. Cockerill, Y. Khew-Goodall, A. G. Bert, P. J. Barter, and M. A. Vadas. 1998. Tumor necrosis factor-α induces adhesion molecule expression through the sphingosine kinase pathway. Proc. Natl. Acad. Sci. USA. 95: 14196-14201.
100. Suc, I., I. Escargueil-Blanc, M. Troly, R. Salvayre, and A. Negre-Salvayre. 1997. HDL and apoA-I prevent cell death of endothelial cells induced by oxidised LDL. Arterioscler. Thromb. Vasc. Biol. 17: 2158-2166.